vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Noble Corp plc (NE). Click either name above to swap in a different company.

Noble Corp plc is the larger business by last-quarter revenue ($764.4M vs $487.7M, roughly 1.6× CLOVER HEALTH INVESTMENTS, CORP.). Noble Corp plc runs the higher net margin — 11.3% vs -10.1%, a 21.4% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -17.6%). Noble Corp plc produced more free cash flow last quarter ($35.4M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 9.5%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.

CLOV vs NE — Head-to-Head

Bigger by revenue
NE
NE
1.6× larger
NE
$764.4M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+62.3% gap
CLOV
44.7%
-17.6%
NE
Higher net margin
NE
NE
21.4% more per $
NE
11.3%
-10.1%
CLOV
More free cash flow
NE
NE
$104.4M more FCF
NE
$35.4M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
9.5%
NE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
NE
NE
Revenue
$487.7M
$764.4M
Net Profit
$-49.3M
$86.6M
Gross Margin
Operating Margin
-10.1%
5.6%
Net Margin
-10.1%
11.3%
Revenue YoY
44.7%
-17.6%
Net Profit YoY
-123.2%
-10.4%
EPS (diluted)
$0.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
NE
NE
Q4 25
$487.7M
$764.4M
Q3 25
$496.6M
$798.0M
Q2 25
$477.6M
$848.7M
Q1 25
$462.3M
$874.5M
Q4 24
$337.0M
$927.3M
Q3 24
$331.0M
$800.5M
Q2 24
$356.3M
$692.8M
Q1 24
$346.9M
$637.1M
Net Profit
CLOV
CLOV
NE
NE
Q4 25
$-49.3M
$86.6M
Q3 25
$-24.4M
$-21.1M
Q2 25
$-10.6M
$42.9M
Q1 25
$-1.3M
$108.3M
Q4 24
$-22.1M
$96.6M
Q3 24
$-9.2M
$61.2M
Q2 24
$7.4M
$195.0M
Q1 24
$-19.2M
$95.5M
Gross Margin
CLOV
CLOV
NE
NE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
NE
NE
Q4 25
-10.1%
5.6%
Q3 25
-4.9%
6.3%
Q2 25
-2.2%
15.9%
Q1 25
-0.3%
21.4%
Q4 24
-6.4%
18.4%
Q3 24
-2.7%
14.4%
Q2 24
2.0%
30.3%
Q1 24
-6.5%
16.9%
Net Margin
CLOV
CLOV
NE
NE
Q4 25
-10.1%
11.3%
Q3 25
-4.9%
-2.6%
Q2 25
-2.2%
5.1%
Q1 25
-0.3%
12.4%
Q4 24
-6.6%
10.4%
Q3 24
-2.8%
7.6%
Q2 24
2.1%
28.1%
Q1 24
-5.5%
15.0%
EPS (diluted)
CLOV
CLOV
NE
NE
Q4 25
$0.54
Q3 25
$-0.13
Q2 25
$0.27
Q1 25
$0.67
Q4 24
$0.56
Q3 24
$0.40
Q2 24
$1.34
Q1 24
$0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
NE
NE
Cash + ST InvestmentsLiquidity on hand
$78.3M
$471.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$4.5B
Total Assets
$541.0M
$7.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
NE
NE
Q4 25
$78.3M
$471.4M
Q3 25
$477.9M
Q2 25
$338.2M
Q1 25
$303.8M
Q4 24
$194.5M
$247.3M
Q3 24
$288.0M
$391.9M
Q2 24
$254.8M
$162.9M
Q1 24
$208.3M
$212.5M
Stockholders' Equity
CLOV
CLOV
NE
NE
Q4 25
$308.7M
$4.5B
Q3 25
$340.9M
$4.5B
Q2 25
$344.2M
$4.6B
Q1 25
$336.1M
$4.7B
Q4 24
$341.1M
$4.7B
Q3 24
$342.2M
$4.7B
Q2 24
$324.9M
$4.0B
Q1 24
$292.5M
$3.9B
Total Assets
CLOV
CLOV
NE
NE
Q4 25
$541.0M
$7.5B
Q3 25
$559.7M
$7.6B
Q2 25
$575.0M
$7.7B
Q1 25
$583.7M
$7.9B
Q4 24
$580.7M
$8.0B
Q3 24
$653.0M
$8.0B
Q2 24
$674.2M
$5.6B
Q1 24
$671.8M
$5.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
NE
NE
Operating Cash FlowLast quarter
$-66.9M
$187.1M
Free Cash FlowOCF − Capex
$-69.0M
$35.4M
FCF MarginFCF / Revenue
-14.1%
4.6%
Capex IntensityCapex / Revenue
0.4%
19.9%
Cash ConversionOCF / Net Profit
2.16×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$432.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
NE
NE
Q4 25
$-66.9M
$187.1M
Q3 25
$12.1M
$277.1M
Q2 25
$5.4M
$216.4M
Q1 25
$-16.3M
$271.1M
Q4 24
$34.8M
$136.2M
Q3 24
$50.0M
$283.8M
Q2 24
$44.8M
$106.8M
Q1 24
$25.9M
$128.7M
Free Cash Flow
CLOV
CLOV
NE
NE
Q4 25
$-69.0M
$35.4M
Q3 25
$11.4M
$139.5M
Q2 25
$4.8M
$99.8M
Q1 25
$-16.5M
$157.5M
Q4 24
$33.3M
$-4.4M
Q3 24
$49.6M
$156.8M
Q2 24
$44.4M
$-34.3M
Q1 24
$25.5M
$-37.9M
FCF Margin
CLOV
CLOV
NE
NE
Q4 25
-14.1%
4.6%
Q3 25
2.3%
17.5%
Q2 25
1.0%
11.8%
Q1 25
-3.6%
18.0%
Q4 24
9.9%
-0.5%
Q3 24
15.0%
19.6%
Q2 24
12.5%
-4.9%
Q1 24
7.3%
-6.0%
Capex Intensity
CLOV
CLOV
NE
NE
Q4 25
0.4%
19.9%
Q3 25
0.1%
17.3%
Q2 25
0.1%
13.7%
Q1 25
0.0%
13.0%
Q4 24
0.5%
15.2%
Q3 24
0.1%
15.9%
Q2 24
0.1%
20.4%
Q1 24
0.1%
26.2%
Cash Conversion
CLOV
CLOV
NE
NE
Q4 25
2.16×
Q3 25
Q2 25
5.05×
Q1 25
2.50×
Q4 24
1.41×
Q3 24
4.64×
Q2 24
6.04×
0.55×
Q1 24
1.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

NE
NE

Floaters$559.8M73%
Jackups$145.5M19%
Service Other$59.1M8%

Related Comparisons